Basic Information
RNALocate ID: | RLID:11001324 |
RNA Symbol: | hsa-miR-148a-3p |
Localization: | Extracellular vesicle |
RNA Information
RNA Name: | hsa-miR-148a |
RNA ID: | miRBase:MIMAT0000243 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 22849433 |
Tissue/Cell Line: | HEK-293T cells |
Method: | Next-generation RNA sequencing |
Description: | The total numbers of reads >15 bp matching each miRNA were calculated. These values were then normalized to number of reads per million mapped (RPMM) in each library, to enable direct comparison of expression levels. As a measure of the relative levels of expression of individual miRNAs in cells and EVs, the log (base two) of the ratio of the read number in EVs over that in cells was calculated (log2 (EV/cell)). The miRNA expression data for cells and EVs is presented in Additional file 1: Table S1. Data are collected from Table S1. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01001570 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:11001317 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
RLID:11001318 | Exosome | Breast milk | 22211110 |
RLID:11001319 | Exosome | Brain tissue | 23382797 |
RLID:11001320 | Exosome | Plasma | 23663360 |
RLID:11001321 | Exosome | Human mast cell line (HMC-1) | 24009880 |
RLID:11001322 | Exosome | Human esophageal cancer cell line (EC9706) | 25184951 |
RLID:11001323 | Exosome | Saliva | 25376581 |
RLID:11001325 | Microvesicle | Seminal plasma | 23539611 |
RLID:11001326 | Microvesicle | Hepatoma cells | 23771658 |
RLID-D:11000041 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Kidney tissue|Lymphoma tissue|Mast cells|Seminal fluid|Tongue tissue | |
RLID-D:11000310 | Microvesicle | Blood|Breast cell line|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-148a-3p | Splenic marginal zone lymphoma | MNDR-E-MI-15916 |
MNDR | hsa-miR-148a-3p | Multiple sclerosis chronic progressive | MNDR-E-MI-15917 |
MNDR | hsa-miR-148a-3p | Oral squamous cell carcinoma | MNDR-E-MI-15918 |
MNDR | hsa-miR-148a-3p | Medulloblastoma | MNDR-E-MI-15919 |
MNDR | hsa-miR-148a-3p | Lymphoma | MNDR-E-MI-15920 |
MNDR | hsa-miR-148a-3p | Lymphoma non-hodgkin | MNDR-E-MI-15921 |
MNDR | hsa-miR-148a-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-15922 |
MNDR | hsa-miR-148a-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-15923 |
MNDR | hsa-miR-148a-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-15924 |
MNDR | hsa-miR-148a-3p | Breast cancer luminal | MNDR-E-MI-15925 |
MNDR | hsa-miR-148a-3p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-15926 |
MNDR | hsa-miR-148a-3p | Autosomal recessive limb-girdle muscular dystrophy type 2a | MNDR-E-MI-15927 |
MNDR | hsa-miR-148a-3p | Dermatomyositis | MNDR-E-MI-15928 |
MNDR | hsa-miR-148a-3p | Castration-resistant prostate cancer | MNDR-E-MI-15929 |
MNDR | hsa-miR-148a-3p | Gastric cancer | MNDR-E-MI-15930 |
MNDR | hsa-miR-148a-3p | Alzheimer disease | MNDR-E-MI-15931 |
MNDR | hsa-miR-148a-3p | Intracranial aneurysm | MNDR-E-MI-15932 |
MNDR | hsa-miR-148a-3p | Bladder cancer | MNDR-E-MI-15933 |
MNDR | hsa-miR-148a-3p | Esophageal carcinoma | MNDR-E-MI-15934 |
MNDR | hsa-miR-148a-3p | Dysautonomia familial | MNDR-E-MI-15935 |
MNDR | hsa-miR-148a-3p | Myotonic dystrophy | MNDR-E-MI-15936 |
MNDR | hsa-miR-148a-3p | Muscular dystrophy duchenne | MNDR-E-MI-15937 |
MNDR | hsa-miR-148a-3p | Leukemia | MNDR-E-MI-15938 |
MNDR | hsa-miR-148a-3p | Huntington disease | MNDR-E-MI-15939 |
MNDR | hsa-miR-148a-3p | Chorea | MNDR-E-MI-15940 |
MNDR | hsa-miR-148a-3p | Cardiovascular disease | MNDR-E-MI-15941 |
MNDR | hsa-miR-148a-3p | Parkinson disease | MNDR-E-MI-15942 |
MNDR | hsa-miR-148a-3p | Breast cancer | MNDR-E-MI-15943 |
MNDR | hsa-miR-148a-3p | Neuroendocrine neoplasia | MNDR-E-MI-15944 |
MNDR | hsa-miR-148a-3p | Pituitary neoplasms | MNDR-E-MI-15945 |
MNDR | hsa-miR-148a-3p | Pancreatic cancer | MNDR-E-MI-15946 |
MNDR | hsa-miR-148a-3p | Intrahepatic cholestasis | MNDR-E-MI-15947 |
MNDR | hsa-miR-148a-3p | Melanoma | MNDR-E-MI-15948 |
MNDR | hsa-miR-148a-3p | Rectum adenocarcinoma | MNDR-E-MI-15949 |
MNDR | hsa-miR-148a-3p | Nephroblastoma | MNDR-E-MI-15950 |
MNDR | hsa-miR-148a-3p | Colon cancer | MNDR-E-MI-15951 |
MNDR | hsa-miR-148a-3p | Ischemic attack transient | MNDR-E-MI-15952 |
MNDR | hsa-miR-148a-3p | Colon adenocarcinoma | MNDR-E-MI-15953 |
MNDR | hsa-miR-148a-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-15954 |
MNDR | hsa-miR-148a-3p | Familial ovarian cancer | MNDR-E-MI-15955 |
MNDR | hsa-miR-148a-3p | Prostate adenocarcinoma | MNDR-E-MI-15956 |
MNDR | hsa-miR-148a-3p | Hematologic cancer | MNDR-E-MI-15957 |
MNDR | hsa-miR-148a-3p | Carcinoma ductal breast | MNDR-E-MI-15958 |
MNDR | hsa-miR-148a-3p | Glioblastoma | MNDR-E-MI-15959 |
MNDR | hsa-miR-148a-3p | Glioma | MNDR-E-MI-15960 |
MNDR | hsa-miR-148a-3p | Nemaline myopathy | MNDR-E-MI-15961 |
MNDR | hsa-miR-148a-3p | Central nervous system lymphoma | MNDR-E-MI-15962 |
MNDR | hsa-miR-148a-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-15963 |
MNDR | hsa-miR-148a-3p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-15964 |
MNDR | hsa-miR-148a-3p | Uterine cancer | MNDR-E-MI-15965 |
MNDR | hsa-miR-148a-3p | Cervical squamous cell carcinoma | MNDR-E-MI-15966 |
MNDR | hsa-miR-148a-3p | Pituitary adenoma | MNDR-E-MI-15967 |
MNDR | hsa-miR-148a-3p | Lung squamous cell carcinoma | MNDR-E-MI-15968 |
MNDR | hsa-miR-148a-3p | Lung adenocarcinoma | MNDR-E-MI-15969 |
MNDR | hsa-miR-148a-3p | Acute myocarditis | MNDR-E-MI-15970 |
MNDR | hsa-miR-148a-3p | Thyroid carcinoma | MNDR-E-MI-15971 |
MNDR | hsa-miR-148a-3p | Bladder urothelial carcinoma | MNDR-E-MI-15972 |
MNDR | hsa-miR-148a-3p | Pancreatic adenocarcinoma | MNDR-E-MI-15973 |
MNDR | hsa-miR-148a-3p | Skin cancer | MNDR-E-MI-15974 |
MNDR | hsa-miR-148a-3p | Kidney renal clear cell carcinoma | MNDR-E-MI-15975 |
MNDR | hsa-miR-148a-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-15976 |
MNDR | hsa-miR-148a-3p | Renal clear cell carcinoma | MNDR-E-MI-15977 |
MNDR | hsa-miR-148a-3p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-15978 |
MNDR | hsa-miR-148a-3p | Cholangiocarcinoma | MNDR-E-MI-15979 |
MNDR | hsa-miR-148a-3p | Esophageal cancer | MNDR-E-MI-15980 |
MNDR | hsa-miR-148a-3p | Liver cirrhosis | MNDR-E-MI-15981 |
MNDR | hsa-miR-148a-3p | Lung small cell carcinoma | MNDR-E-MI-15982 |
MNDR | hsa-miR-148a-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-15983 |
MNDR | hsa-miR-148a-3p | Aortic valve disease | MNDR-E-MI-15984 |
MNDR | hsa-miR-148a-3p | Breast invasive carcinoma | MNDR-E-MI-15985 |
MNDR | hsa-miR-148a-3p | Early hepatocellular carcinoma | MNDR-E-MI-15986 |
MNDR | hsa-miR-148a-3p | Familiar ovarian carcinoma | MNDR-E-MI-15987 |
MNDR | hsa-miR-148a-3p | B-cell lymphoma | MNDR-E-MI-15988 |
MNDR | hsa-miR-148a-3p | Rheumatoid arthritis | MNDR-E-MI-15989 |
MNDR | hsa-miR-148a-3p | T-cell leukemia | MNDR-E-MI-15990 |
MNDR | hsa-miR-148a-3p | Malignant pleural mesothelioma | MNDR-E-MI-15991 |
MNDR | hsa-miR-148a-3p | Hodgkin lymphoma | MNDR-E-MI-15992 |
MNDR | hsa-miR-148a-3p | Burkitt lymphoma | MNDR-E-MI-15993 |
MNDR | hsa-miR-148a-3p | Neuromyelitis optica | MNDR-E-MI-15994 |
MNDR | hsa-miR-148a-3p | Skin cutaneous melanoma | MNDR-E-MI-15995 |
MNDR | hsa-miR-148a-3p | Skin melanoma | MNDR-E-MI-15996 |
MNDR | hsa-miR-148a-3p | Acute myelocytic leukemia | MNDR-E-MI-15997 |
MNDR | hsa-miR-148a-3p | Colorectal cancer | MNDR-E-MI-15998 |
MNDR | hsa-miR-148a-3p | Multiple myeloma | MNDR-E-MI-15999 |
MNDR | hsa-miR-148a-3p | Acute lymphocytic leukemia | MNDR-E-MI-16000 |
MNDR | hsa-miR-148a-3p | Ependymoma | MNDR-E-MI-16001 |
MNDR | hsa-miR-148a-3p | Nasopharyngeal cancer | MNDR-E-MI-16002 |
MNDR | hsa-miR-148a-3p | Epstein-barr virus infections | MNDR-E-MI-16003 |
MNDR | hsa-miR-148a-3p | Stroke lacunar | MNDR-E-MI-16004 |
MNDR | hsa-miR-148a-3p | Low grade dysplastic nodule | MNDR-E-MI-16005 |
MNDR | hsa-miR-148a-3p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-16006 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ACVR1 | Homo sapiens | RR00038737 |
TOP